×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Maky Zanganeh

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
SMMTSummit Therapeutics Inc.Mahkam ZanganehCo-Chief Executive OfficerMay 30, 2025Option/RSU Exercise$2.6474,545196,799555,754,696Jun 02, 2025, 05:01 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehCo-Chief Executive OfficerApr 08, 2025ATM/ITM Option Exercise$1.583,985,0556,296,387555,680,151Apr 09, 2025, 05:19 PM
PLSEPULSE BIOSCIENCES, INC.Mahkam ZanganehDirectorJan 24, 2025ATM/ITM Option Exercise$11.0030,121331,331695,274Feb 11, 2025, 06:20 PM
PLSEPULSE BIOSCIENCES, INC.Mahkam ZanganehDirectorFeb 03, 2025ATM/ITM Option Exercise$11.0030,121331,331725,395Feb 11, 2025, 06:20 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehCo-Chief Executive OfficerOct 03, 2024ATM/ITM Option Exercise$1.58315,681498,77610,199,776Oct 03, 2024, 04:54 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehCo-Chief Executive OfficerSep 11, 2024Award/Grant$22.7044,052999,98024,967,852Sep 13, 2024, 07:29 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehChief Executive OfficerMar 27, 2024Buy$3.7120,00074,20050,000Mar 27, 2024, 08:28 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehChief Executive OfficerMar 26, 2024Buy$3.7530,000112,50030,000Mar 27, 2024, 08:28 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehChief Executive OfficerMar 27, 2024Buy$3.7226,00096,720520,814Mar 27, 2024, 08:28 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehChief Executive OfficerMar 27, 2024Buy$3.7234,321127,67424,923,800Mar 27, 2024, 08:28 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehChief Executive OfficerDec 11, 2023ATM/ITM Option Exercise$1.58315,681498,77624,889,479Dec 13, 2023, 05:11 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehChief Executive OfficerDec 12, 2023Buy$2.075,00010,350494,814Dec 13, 2023, 05:11 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehChief Executive OfficerDec 11, 2023ATM/ITM Option Exercise$1.44489,814705,332489,814Dec 13, 2023, 05:11 PM
PLSEPulse Biosciences, Inc.Mahkam ZanganehDirectorNov 13, 2023Option/RSU Exercise$2.1476,075162,801604,911Nov 15, 2023, 05:37 PM
PLSEPulse Biosciences, Inc.Mahkam ZanganehDirectorJun 09, 2023ATM/ITM Option Exercise$2.0586,668177,669528,836Jul 06, 2023, 08:30 PM
PLSEPulse Biosciences, Inc.Mahkam ZanganehDirectorJun 09, 2023ATM/ITM Option Exercise$2.0586,668177,669791,915Jun 13, 2023, 05:26 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehCo-CEO & PresidentMar 08, 2023Buy$1.056,748,6297,086,0609,884,095Mar 13, 2023, 06:27 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehCo-CEO & PresidentMar 08, 2023Buy$1.0516,778,41517,617,33524,573,798Mar 13, 2023, 06:27 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehCo-Chief Executive OfficerMar 08, 2023Buy$1.0515,973,74316,772,42923,395,269Mar 08, 2023, 09:31 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehCo-Chief Executive OfficerMar 08, 2023Buy$1.05804,672844,9061,178,529Mar 08, 2023, 09:31 PM
SMMTSummit Therapeutics Inc.Mahkam ZanganehCo-Chief Executive OfficerMar 08, 2023Buy$1.056,748,6297,086,0609,884,095Mar 08, 2023, 09:31 PM
SMMTSummit Therapeutics Inc.Maky ZanganehCo-CEO & PresidentAug 16, 2022Buy$0.974,593,7774,455,9647,061,557Aug 18, 2022, 04:36 PM
SMMTSummit Therapeutics Inc.Maky ZanganehCo-CEO & PresidentAug 16, 2022Buy$0.971,030,925999,9973,135,466Aug 18, 2022, 04:36 PM
SMMTSummit Therapeutics Inc.Maky ZanganehCo-CEO & PresidentAug 16, 2022Buy$0.97184,430178,897359,969Aug 18, 2022, 04:36 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorJan 08, 2021ATM/ITM Option Exercise$7.013,00021,030355,500Jan 21, 2021, 04:32 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorJan 19, 2021ATM/ITM Option Exercise$7.013072,152107,074Jan 21, 2021, 04:32 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorJun 23, 2020Buy$10.701,19312,767106,767Jun 25, 2020, 05:12 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorJun 17, 2020Buy$7.017,95055,730105,574Jun 19, 2020, 04:22 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorJun 15, 2020ATM/ITM Option Exercise$7.0120,000140,200352,500Jun 17, 2020, 04:09 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorJun 15, 2020ATM/ITM Option Exercise$7.012,05014,37197,624Jun 17, 2020, 04:09 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorDec 13, 2017Buy$23.981,10026,37895,574Dec 15, 2017, 04:19 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorDec 11, 2017Buy$22.763,00068,28993,474Dec 13, 2017, 08:30 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorDec 12, 2017Buy$23.981,00023,97994,474Dec 13, 2017, 08:30 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorSep 14, 2017Buy$12.7722,000280,879324,725Sep 18, 2017, 09:07 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorSep 18, 2017Buy$15.027,775116,791332,500Sep 18, 2017, 09:07 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorAug 02, 2017Buy$25.158,290208,469287,225Aug 04, 2017, 05:46 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorAug 03, 2017Buy$23.6315,500366,317302,725Aug 04, 2017, 05:46 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorAug 03, 2017Buy$23.005,000115,01590,474Aug 04, 2017, 05:46 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorMay 11, 2017Buy$20.8415,000312,540278,935May 11, 2017, 08:03 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorMay 09, 2017Buy$20.1633,760680,50080,474May 11, 2017, 08:03 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorMay 10, 2017Buy$21.715,000108,54585,474May 11, 2017, 08:03 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorMar 17, 2017Buy$24.008,960215,00442,434Mar 20, 2017, 09:48 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorMar 20, 2017Buy$22.475,000112,360263,935Mar 20, 2017, 09:48 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorMar 20, 2017Buy$22.974,28098,30546,714Mar 20, 2017, 09:48 PM
PLSEPulse Biosciences, Inc.Maky ZanganehDirectorFeb 15, 2017Buy$11.9713,000155,64933,474Feb 22, 2017, 02:48 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe